RIGEL PHARMACEUTICALS INC Quarterly Current Ratio in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Rigel Pharmaceuticals Inc quarterly Current Ratio history and growth rate from Q1 2012 to Q3 2024.
  • Rigel Pharmaceuticals Inc Current Ratio for the quarter ending September 30, 2024 was 164 %, a 20.4% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 164 -42.2 -20.4% Sep 30, 2024
Q2 2024 163 -51.5 -24% Jun 30, 2024
Q1 2024 177 -35.9 -16.8% Mar 31, 2024
Q4 2023 210 -3.85 -1.8% Dec 31, 2023
Q3 2023 206 -26.8 -11.5% Sep 30, 2023
Q2 2023 215 -31.9 -12.9% Jun 30, 2023
Q1 2023 213 -55.4 -20.6% Mar 31, 2023
Q4 2022 214 -87.1 -28.9% Dec 31, 2022
Q3 2022 233 -69.8 -23% Sep 30, 2022
Q2 2022 247 -58.5 -19.2% Jun 30, 2022
Q1 2022 269 -39.7 -12.9% Mar 31, 2022
Q4 2021 301 +4.71 +1.59% Dec 31, 2021
Q3 2021 303 +19.7 +6.96% Sep 30, 2021
Q2 2021 305 -0.43 -0.14% Jun 30, 2021
Q1 2021 308 -18.4 -5.63% Mar 31, 2021
Q4 2020 297 -57.3 -16.2% Dec 31, 2020
Q3 2020 283 -182 -39.1% Sep 30, 2020
Q2 2020 306 -206 -40.3% Jun 30, 2020
Q1 2020 327 -263 -44.6% Mar 31, 2020
Q4 2019 354 -237 -40.1% Dec 31, 2019
Q3 2019 465 -174 -27.2% Sep 30, 2019
Q2 2019 512 -96.3 -15.8% Jun 30, 2019
Q1 2019 590 +49.6 +9.19% Mar 31, 2019
Q4 2018 591 +33.5 +6.01% Dec 31, 2018
Q3 2018 639 +174 +37.3% Sep 30, 2018
Q2 2018 608 +155 +34.2% Jun 30, 2018
Q1 2018 540 +105 +24% Mar 31, 2018
Q4 2017 557 +164 +41.8% Dec 31, 2017
Q3 2017 465 +63.9 +15.9% Sep 30, 2017
Q2 2017 453 +58.2 +14.7% Jun 30, 2017
Q1 2017 436 +40 +10.1% Mar 31, 2017
Q4 2016 393 -24.9 -5.96% Dec 31, 2016
Q3 2016 401 -105 -20.8% Sep 30, 2016
Q2 2016 395 -271 -40.6% Jun 30, 2016
Q1 2016 396 -551 -58.2% Mar 31, 2016
Q4 2015 418 -1.21K -74.3% Dec 31, 2015
Q3 2015 507 -1.46K -74.2% Sep 30, 2015
Q2 2015 666 -1.6K -70.6% Jun 30, 2015
Q1 2015 946 -1.65K -63.5% Mar 31, 2015
Q4 2014 1.62K -1.09K -40.1% Dec 31, 2014
Q3 2014 1.96K -830 -29.7% Sep 30, 2014
Q2 2014 2.27K -253 -10% Jun 30, 2014
Q1 2014 2.59K +250 +10.7% Mar 31, 2014
Q4 2013 2.71K +429 +18.8% Dec 31, 2013
Q3 2013 2.79K +601 +27.4% Sep 30, 2013
Q2 2013 2.52K -16.3 -0.64% Jun 30, 2013
Q1 2013 2.34K -530 -18.4% Mar 31, 2013
Q4 2012 2.29K Dec 31, 2012
Q3 2012 2.19K Sep 30, 2012
Q2 2012 2.54K Jun 30, 2012
Q1 2012 2.87K Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.